Screener
Globus Medical GMED Enabling Technologies — Net Sales
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Globus Medical’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054450
| (In thousands) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Musculoskeletal Solutions | $763,540 | $710,182 | $1,496,524 | $1,286,115 |
| Enabling Technologies | 26,072 | 35,160 | 52,942 | 57,348 |
| Total net sales | $789,612 | $745,342 | $1,549,466 | $1,343,463 |
Item 1. Financial Statements
FAQ
- What is Globus Medical's enabling technologies — net sales?
- Globus Medical (GMED) reported enabling technologies — net sales of $26.07M in Q2 2026.
- How has Globus Medical's enabling technologies — net sales changed year-over-year?
- Globus Medical's enabling technologies — net sales decreased by 25.8% year-over-year, from $35.16M to $26.07M.
- What does enabling technologies — net sales mean?
- This metric represents the total revenue generated from the sale of advanced computer systems, robotics, and navigation platforms designed to enhance surgical precision and procedural outcomes. It reflects the company's success in commercializing high-tech capital equipment and associated service contracts within the medical device market. This segment is a key indicator of the company's innovation strategy and its ability to integrate digital solutions into traditional orthopedic and spinal surgical workflows.
Ask your AI about Globus Medical's enabling technologies — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude